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A B S T R A C T
Chronic dietary bioaccumulation tests with rodents are required for new substances, including engineered na-
nomaterials (ENMs), in order to provide information on the potential hazards to human health. However,
screening tools are needed to manage the diversity of ENMs and alternative methods are desirable with respect
to animal welfare. Here, an ex vivo gut sac method was used to estimate the dietary bioaccumulation potential of
silver nanomaterials. The entire gastrointestinal tract (except the caecum) was removed and filled with a gut
saline containing 1 mg L−1 of Ag as either AgNO3, silver nanoparticles (Ag NPs) or silver sulphide nanoparticles
(Ag2S NPs), and compared to controls with no added Ag. The gut sacs were incubated for 4 h, rinsed to remove
excess media, and the total Ag determined in the mucosa and muscularis. There was no detected Ag in the
control treatments. Within the Ag treatments, 1.4–22% of the exposure dose was associated with the tissues and
serosal saline. Within the mucosa of the AgNO3 treatment, the highest Ag concentration was associated with the
intestinal regions (3639–7087 ng g−1) compared to the stomach (639 ± 128 ng g−1). This pattern was also
observed in the Ag NP and Ag2S NP treatments, but there was no significant differences between any Ag
treatments for the mucosa. However, differences between treatments were observed in the muscularis con-
centration. For example, both the Ag NP (907 ± 284 ng g −1) and Ag2S NP (1482 ± 668 ng g−1) treatments
were significantly lower compared to the AgNO3 treatment (2514 ± 267 ng g−1). The duodenum demonstrated
serosal accumulation in both the AgNO3 (~10 ng mL−1) and Ag NP (~3 ng mL−1) treatments. The duodenum
showed some of the highest Ag accumulation with 41, 61 and 57% of the total Ag in the mucosa compared to the
muscularis for the AgNO3, Ag NP and Ag2S NP treatments, respectively. In conclusion, the ex vivo gut sac method
demonstrates the uptake of Ag in all Ag treatments, with the duodenum the site of highest accumulation. Based
on the serosal saline accumulation, the ranked order of accumulation is AgNO3 > Ag NPs > Ag2S NPs.
1. Introduction
Engineered nanomaterials (ENMs) are being incorporated into food
and food-based products (reviews, Bouwmeester et al., 2014; Chaudhry
et al., 2008; Tiede, 2008), and inevitably there is the potential for
human exposure of the gastrointestinal tract (GIT); yet the subsequent
accumulation of ENMs across the mammalian GIT remains unclear.
There are also concerns that ENMs can be incidentally incorporated into
the human food chain from agriculture (e.g., nano pesticides) as well as
from food processing, including anti-caking agents (Martirosyan and
Schneider, 2014). Indeed, ENMs are also intended for direct con-
sumption in health foods and nutritional supplements (Katouzian and
Jafari, 2016), as well as in oral medicines for improved drug delivery or
as inert fillers in the manufacture of pills (Bobo et al., 2016). Data on
the measured concentrations of ENMs in food are now beginning to
emerge (e.g., confectionary, Peters et al., 2014b; chicken meat, Peters
et al., 2014a). The inclusion of metal-containing ENMs can be a few μg
kg−1 of food (e.g., TiO2, Weir et al., 2012), to mg L−1 concentration in
sports drinks (e.g., silver, Reed et al., 2014).
For the nutritionally required metals such as Cu, the solute transport
pathways are well described, and the export of metal from the gut
epithelial cell to the blood is concentration-dependent and the rate
limiting step in absorption (Handy et al., 2000; Linder, 2002). Non-
essential metals, such as Hg may also use some of these pathways
(Hoyle and Handy, 2005), but the situation for dissolved Ag is less clear
in mammals. Alternatively, ENMs may be taken up in the particulate
form. The apical uptake (i.e., from the gut lumen side into the cells) of
intact particles has been demonstrated in cultures of intestinal
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epithelial cells (Caco-2) and the uptake may also be dependent on the
crystal structure of the material (e.g., TiO2, Gitrowski et al., 2014), and/
or particle size (e.g., silver, van der Zande et al., 2016). For the mam-
malian gut, in vivo, the M cells of the Peyer's patches are especially
associated with the uptake of iron particles (Powell et al., 2010) and
one concern is that these specialised structures could be a route for the
preferential accumulation of particulates across the gastrointestinal
tract. For TiO2 in rodents at least, only a small fraction of the ingested
dose is taken up as particles in vivo (Kreyling et al., 2017). For Ag NPs,
oral gavage studies lasting 86 days show approximately 5–37 ng g−1 of
total Ag in the internal organs and with the most in the liver (van der
Zande et al., 2012). A similar oral gavage study with Ag NPs in rodents
over 28 days found approximately 0.1–2.6 μg g−1 wet weight of total
Ag in the internal organs, with most in the liver and kidney (Loeschner
et al., 2011). The latter reported negligible Ag excretion in the urine.
Both studies reported more total Ag in the internal organs from ex-
posure to dissolved silver salts than from exposure to the nanomaterials.
Although there have been oral gavage studies with rodents showing
that ENMs can be taken up (form unknown) via the gut into the internal
organs, the precise mechanisms of uptake for Ag NPs is unclear. Silver
NPs may show some dissolution under the simulated acid conditions
found in the stomach (Clark et al., 2019a), but any Ag could form a
sparingly soluble AgCl particulate in the intestine (see discussion in
Clark et al., 2019b). Such particles formed from the dissolved metal
have also been detected in the internal organs (in trout, Clark et al.,
2019c). Pristine Ag NPs may also be transformed into sparingly soluble
Ag2S NPs by sulfidation reactions (Lead et al., 2018). In the gut lumen,
Ag NPs will inevitably be in close association with the food matrix
which is enriched with sulphur residues (see Peters et al., 2014a), and
in the reducing environment of the lumen (Wien and Van Campen,
1991), silver sulphide nanoparticles will form. Consequently, the sul-
fidised form of Ag should also be included in the hazard assessment.
In Europe, oral toxicity tests with rodents are a mandatory part of
hazard assessment of new substances, including ENMs, and especially
when oral exposure to humans is a route of concern (e.g., TG 407 OECD,
2008). However, with a myriad of forms and chemistries of ENMs, there
are too many variants of the materials to test each one as a new sub-
stance, and so screening methods are needed to identify ENMs that
present a bioaccumulation concern, as well as to reduce the burden of
animal testing (Handy et al., 2018). In vitro studies with gut cell cul-
tures show that Ag accumulation from AgNO3 has shown a chloride
dependence, but not for Ag accumulation from citrate-coated Ag NPs
(RTgutGC cells, Minghetti and Schirmer, 2016). However, this chloride
dependent effect on Ag accumulation in gut epithelial cells is not ob-
served in whole gut tissue, and is likely masked by the effects of mucus
and the electrophysiological properties of the intact gut (Clark et al.,
2019b); demonstrating the importance of this physiology. Nonetheless,
reducing the need for in vivo testing is desirable and the ex vivo gut sac
retains the physiological integrity observed in vivo.
The use of gut sacs from rodents has been long established for in-
vestigating gastrointestinal physiology (Wilson and Wiseman, 1954),
the uptake of metals (Cu, Wapnir and Stiel, 1987; Cd, Hoadley and
Johnson, 1987), but not so far applied to ENMs. The present study
aimed to determine the bioavailability of Ag materials to the different
anatomical regions of the rodent gastrointestinal tract when presented
as either AgNO3, Ag NPs or Ag2S NPs. The serosal solution was also
explored for evidence of any transepithelial uptake of Ag materials. The
experimental approach used the same methodology as our previous
report on the gut sacs of rainbow trout exposed to silver (Clark et al.,
2019b) to enable a direct cross-species comparison between fish and
rodents for exactly the same batches of nanomaterial.
2. Methodology
2.1. Stock animals
Wistar rats (Rattus norvegicus) were bred in house at Plymouth
University and kept until 7 weeks old. Rats (n = 24), weighing
100–150 g, were housed in cages maintained at 20 ± 2 °C, humidity
55 ± 10%, and with a 12-h light/dark cycle and light intensity be-
tween 320 and 290 lux. Animals had free access to drinking water and
food. Rats were fed a commercially available diet (RM3A [P], 9.5 mm
pellets, Special Diet Services, England), containing crude fat, protein,
fibre and ash of 4.2, 22.4, 4.2 and 7.6%, respectively. Prior to the ex-
periments, food was withheld for 24 h to aid in the evacuation of the
gastrointestinal tract and faecal material was continuously removed to
prevent coprophagic behaviour. Despite these efforts to clear the gas-
trointestinal tract, the caecum still contained food material and so this
part of the tissue was excluded from the experiment to minimise the risk
of uneaten food particulates confounding the results.
2.2. Preparation and characterisation of silver nanomaterials and silver
nitrate
The same Ag NPs and Ag2S NPs were used here as reported in Clark
et al. (2019b) and details of the materials can be found therein. Both Ag
nanomaterials were solid spherical particles (not hollow or porous)
made from silver, and supplied from Applied Nanoparticles (Barce-
lona). The Ag NPs and Ag2S NPs had nominal sizes of 60 and 35 nm,
respectively, and at a total Ag concentration of 10.8 and 14 g L−1,
respectively. The Ag NP material was dispersed in 25 μM tannic acid
and 5.5 mM sodium citrate, and the Ag2S NPs were dispersed in
1 mg mL−1 polyvinylpyrrolidone. Transmission electron microscopy
showed the primary particle size (diameters of the particles in dried
electron microscopy samples) for the Ag NPs and Ag2S NPs to be
55 ± 3 and 37 ± 19 nm, respectively (n = 120 and 103, respec-
tively). The hydrodynamic diameters of ENMs in dispersions were
measured by Nanoparticle Tracking Analysis (NTA, Nanosight, LM10).
The hydrodynamic diameters of the Ag ENMs were made in either ul-
trapure water adjusted to pH 7.4 using 0.04 M NaOH, or physiological
gut saline pH 7.4 (see recipe below, and NTA plots in Fig. 1) using
primer plus grade nitric acid. The mean hydrodynamic diameter of the
Ag NPs and Ag2S NPs were 77 ± 10 and 123 ± 7 nm, respectively. In
the physiological gut saline, the measured hydrodynamic diameter of
the Ag NPs and Ag2S NPs were 116 ± 19 and 134 ± 17 nm, re-
spectively (Fig. 1). Further characterisation is detailed in Clark et al.
(2019b).
2.3. Gut sac preparation
The gut sac technique used was described in Clark et al. (2019b),
with minor modifications here for the physiological differences be-
tween fish and rodents. Rats were weighed and then euthanized by
exposure to a rising concentration of CO2 followed by cervical dis-
location; an approved Schedule 1 method, and with the entire experi-
ment in accordance with ethical approval from the U.K. Home Office
and in compliance with the European directive 2010/63/EU. The entire
GIT was removed and separated into the following anatomical regions:
oesophagus, stomach, duodenum, jejunum, ileum, caecum and hind
intestine. Due to their large size, the intestinal regions (duodenum,
jejunum, ileum and hind intestine) were dissected into smaller three
inch sections to facilitate the preparation of the gut sac (Wilson and
Wiseman, 1954). This approach also allowed the uniform filling of the
anatomical regions of the gut to equal fullness with the test media and
thus helped standardise the exposure (see below).
The gut regions were washed in a gut physiological saline (in mM:
NaCl, 117.5; KCl, 5.7; NaHCO3, 25.0; NaH2PO4.H2O, 1.2; CaCl2, 2.5;
MgSO4.7H2O, 1.2; glucose, 5.0; mannitol, 23.0; pH 7.4) and weighed.
N.J. Clark, et al. Ecotoxicology and Environmental Safety 200 (2020) 110745
2
Each gut sac was closed at one end using surgical suture thread and
filled with the relevant saline solution containing either no added Ag
(as above), or 1 mg L−1 Ag as AgNO3, Ag NPs or Ag2S NPs. The silver
speciation from the AgNO3 in the gut saline above (pristine, no contact
with rat tissue) was theoretically calculated using Visual MINTEQ 3.1
by J. P. Gustafsson (https://vminteq.lwr.kth.se/download/). The cal-
culated silver species in the normal gut saline containing chloride was:
Ag+, 0.077%; AgCl (aq), 8.2947%; AgCl2−, 81.208%; and AgCl32−,
10.420%. The sacs were subsequently closed with suture thread and
weighed to calculate the volume of respective saline solution added.
The gut sacs were then incubated in the gut physiological saline for
4 h at 37 °C.
Following the 4 h incubation, the gut sacs were removed and
weighed for fluid flux calculations according to Clark et al. (2019b).
Then, the gut sacs were carefully cut open and rinsed into 5 mL of clean
gut physiological saline to collect the luminal contents. Tissues were
then rinsed in a second 5 mL of solution containing gut physiological
saline with 1 mM EDTA and blotted with 25 cm2 pieces of tissue paper
(4 pieces for the stomach and 2 for the oesophagus and intestinal re-
gions) to remove surface bound material [ < 5% adsorbed; see surface
binding experiment in Clark et al. (2019b)]. This blotting paper was
kept in the EDTA rinse and processed as described below. The rinse
solutions were frozen at −20 °C until processing for metal analysis.
Following the rinse solutions, the mucosa was separated from the
muscularis by using a glass microscope slide, both parts of the tissue
were weighed and stored at −20 °C. The tissues were then freeze dried
and reweighed before acid digestion for total Ag and electrolyte ana-
lysis (see below).
2.4. Total Ag, Na and K analysis
Analysis of the luminal saline, EDTA rinse solutions, and tissues
were performed according to Clark et al. (2019b). Briefly, the samples
were thawed, acidified with 2 mL of primer plus grade nitric acid, di-
luted with ultrapure water (containing internal standards of indium and
iridium) to 20 mL and left over night before analysing for total Ag
concentration using an ICP-MS (iCAP RQ Thermo Fisher). All samples
were analysed using matrix matched standards and procedural blanks
to account for trace elements from tubes and reagents. For the tissues,
each piece of tissue was digested in 0.2 mL of analytical grade nitric
acid (0.5 mL for the muscularis of the stomach) and incubated at 60 °C
for 4 h. The tissues were then diluted to a final volume of 2 mL (3 mL
for the muscularis of the stomach) with 22.2 μg L−1 indium and iridium
spiked ultrapure water. The limit of detection for total Ag of the ICP-MS
was around 0.2 ng mL−1 of tissue digest, which equates to around
10.6 ng g−1 dry weight (dw) of tissue. The Na+ and K+ concentrations
were also measured in the tissue digests. Following Ag analysis, 0.5 mL
of the sample was taken and diluted to 2.5 mL using yttrium (internal
standard) spiked ultrapure water and analysed using an iCAP 7000 ICP-
OES for Na+ and K+.
2.5. Statistical analysis
All data are presented as mean ± S.E.M., unless otherwise stated.
Graphs are presented and statistical analysis conducted in SigmaPlot
13.0. Data (n = 5/6 gut sacs per treatment) was analysed for outliers
using Grubbs test. Data were check for normality (Shapiro-Wilk test)
Fig. 1. The hydrodynamic diameter of Ag NPs and Ag2S NPs in ultrapure water pH 7.4 (A and B, respectively) and physiological gut saline pH 7.4 (C and D,
respectively) measured by NanoSight Tracking Analysis. Data are mean ± S.E.M. (n = 3). Note the increase in frequency of larger bin sizes in the gut physiological
saline treatments.
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and equal variance (Brown Forsythe). Data that were normally dis-
tributed, or could be log10 transformed to become normally distributed,
were analysed by either a one-way ANOVA or two-way ANOVA, and
subsequently checked with a Holm-Sidak post hoc test. Where data
were not parametric, the Kruskal-Wallis test was used and a Tukey's or
Dunns post hoc test.
3. Results
3.1. Ag exposure of gut sacs
Following the 4 h exposure, the gut sacs were cut open and the
contents collected for total Ag analysis. This was followed by an EDTA
wash to ensure loosely bound Ag was removed from the surface of the
mucosa. The presence of Ag in these washes confirmed that the Ag was
in excess throughout the exposure and ensured that any apparent ac-
cumulation by the tissue was not limited by the supply of Ag in the
lumen. As expected, most of the Ag was labile and within the first lu-
minal rinse, although some total Ag was also removed by the EDTA
wash (Table 1).
The washes from the control gut sacs contained no detectable Ag
(Table 1). Within the AgNO3 treatment, the absolute mass of Ag in the
luminal wash ranged from 40 to 300 ng, depending on the gut region.
The highest absolute mass of Ag was in the luminal rinse of the jejunum
and hind intestine which was 2.5-fold higher compared to the luminal
rinse from the oesophagus, although this was not statistically elevated
compared to other gut regions. The pattern of Ag content in the
washings from both the Ag NP and Ag2S NP treatments were similar to
the AgNO3 treatment; with the absolute mass of Ag in the luminal
washes between 20 and 300 ng for the nanomaterials. Within the lu-
minal rinse of the Ag NP treatment, there was significantly more Ag
associated with the rinses from the stomach, jejunum and hind intestine
(all values P < 0.001) compared to the oesophagus. Similarly, within
the Ag2S NP treatment there was a trend for the stomach, jejunum and
hind intestine have more Ag compared to the oesophagus, but there was
no statistical difference between gut regions.
There were also some differences in the residual Ag in the EDTA
wash (Table 1). In the AgNO3 treatment, there was no significant dif-
ference between gut regions, but the tendency was to have higher
concentrations in the EDTA wash associated with the intestinal regions.
In the EDTA wash from the Ag NP treatment, the most total Ag was
associated with the stomach (P = 0.003) and jejunum (P = 0.029)
compared to the oesophagus. There was no significant difference be-
tween the gut regions in the Ag in the EDTA wash of the Ag2S NP
treatment.
The exposure was also confirmed by the measured concentrations of
total Ag in the gut tissues (Table 2). The control tissues (both mucosa
and muscularis) contained no detectable Ag, regardless of gut region
(LOD = 10.6 ng g−1 dw). Within the Ag treatments there was some
material-type and gut region effects on the concentration of total Ag
found in the mucosa following exposure. Within the AgNO3 treatment,
the duodenum (P = 0.006), jejunum (P < 0.001), ileum (P = 0.002)
and hind intestine (P = 0.017) all had significantly higher total Ag
concentrations compared to the stomach. For example, the intestinal
regions contained 7–12 fold higher Ag compared to the stomach
(~640 ng g−1 dw). Similar observations were made by anatomical
region of the gut within the Ag NP and Ag2S NP treatment, with the
jejunum (P < 0.001 and P < 0.001, respectively) and ileum
(P < 0.001 and P = 0.003, respectively) being significantly higher
compared to the stomach. Between the Ag treatments, there was very
little difference except the hind intestine of the Ag2S NP treatment
which contained around a third of the Ag compared to the AgNO3
treatment (~3600 ng g−1 dw). Between the nanomaterials, there was
no significant difference in the total Ag concentration within the mu-
cosa.
There were statistical differences by both treatment and gut region
with respect to the concentration of total Ag in the muscularis. In all the
Ag treatments, the four anatomical regions of the intestine were sig-
nificantly elevated compared to the stomach. For example, in the
AgNO3 treatment, the muscularis of the stomach contained around
100 ng g−1 dw whereas the intestinal regions ranged from 600 to
3500 ng g−1 dw (all values P < 0.001). Additionally, between treat-
ments, the stomach, duodenum, jejunum, ileum and hind intestine (all
values P < 0.001) were all significantly elevated compared to their
respective gut regions from both the Ag NPs and Ag2S NPs treatments.
For example, the duodenum of the AgNO3, Ag NP and Ag2S NP treat-
ments contained around 2500, 900 and 1400 ng g−1 dw, respectively.
The only exception was the muscularis of the oesophagus where the
total Ag concentration in the tissue were the same for the AgNO3
treatment compared to both the Ag NP and Ag2S NP treatments. The
only effect between nanomaterials was observed in the jejunum where
the Ag2S NP treatment had around half the total Ag concentration
compared to the Ag NPs treatment (the latter 685 ng g−1 dw,
P = 0.021).
Table 2 also shows the transepithelial accumulation of total Ag
across the gut into the serosal compartment. Only a few regions of the
gut showed the ability for transepithelial accumulation of Ag and they
were limited to the AgNO3 and Ag NP treatments. In the AgNO3
treatment, the duodenum, jejunum, ileum and hind intestine showed
transepithelial accumulation of total Ag, with there being significantly
more in the serosal saline from the duodenum (P = 0.005), jejunum
(P = 0.038) and ileum (P = 0.017) compared to that from the hind
intestine. The only gut region to show transepithelial accumulation in
the Ag NP treatment was the duodenum with the serosal saline having a
significantly lower total Ag concentration compared to the same region
of the AgNO3 treatment (P = 0.043). There was no evidence of trans-
epithelial accumulation of total Ag into the serosal saline of the Ag2S
NP treatment.
Table 1
Mass of Ag (total in ng) found in the luminal saline (rinse 1) and EDTA wash (rinse 2) to confirm exposure of the rodent gut sacs.

















46.1 ± 12.6 Aa
14.4 ± 1.2 Aa
160.5 ± 52.2 Aa
60.6 ± 15.5 Aa
132.2 ± 15.4 Aa
36.2 ± 3.9 Aa
207.3 ± 36.7 Aa
46.2 ± 7.1 Aa
137.1 ± 32.6 Aa
40.6 ± 8.2 Aa
283.3 ± 34.4 Aa
49.0 ± 5.7 Aa
Ag NPs Luminal saline
EDTA wash
39.9 ± 5.0 Aa
15.0 ± 3.0 Ba
287.5 ± 95.2 Ac
51.9 ± 14.5 Bb
128.7 ± 19.0 Abc
27.3 ± 1.3 Bab
186.2 ± 39.0 Ac
35.9 ± 4.1 Bb
74.8 ± 15.9 Aab
22.9 ± 1.4 Bab
199.9 ± 45.3 Ac
33.0 ± 5.5 Bab
Ag2S NPs Luminal saline
EDTA wash
19.0 ± 2.8 Aa
15.4 ± 0.8 Aa
162.8 ± 55.0 Aa
37.0 ± 6.6 Aa
87.7 ± 19.4 Aa
23.3 ± 2.2 Aa
100.6 ± 34.9 Aa
26.8 ± 4.3 Aa
60.2 ± 16.5 Aa
28.6 ± 5.9 Aa
136.2 ± 38.7 Aa
25.7 ± 4.9 Aa
Data are mean ± S.E.M. (n = 5/6). Different upper case letters denote significance between the luminal saline and EDTA wash (within columns and treatments).
Different lower case letters denote statistical differences between gut regions (rows; Two-way ANOVA). The limit of detection of the instrument was 0.52 ng mL−1
which equates to 10.4 ng Ag in the luminal and EDTA washes.
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3.2. Partitioning of Ag dose in the gut sacs
The percentage of the original exposure dose found in each com-
partment of the gut sac preparations is shown in Table 3. The luminal
rinse contained 67% or more of the total Ag in the gut sacs, and de-
monstrates the different materials were not in limiting supply (Table 3).
In the case of the EDTA wash, there was no treatment related differ-
ences in percent of Ag association, but some changes in gut regions of
the Ag NPs and Ag2S NPs, but not AgNO3 treatment, were observed. For
example, in both nano Ag treatments, there was significantly less per-
cent Ag associated with the EDTA wash of the hind intestine compared
to the oesophagus (Table 3). Regardless, the luminal and EDTA washes
were sufficient enough to remove excess Ag, leaving only a few percent
in the tissues. Interestingly, the transepithelial accumulation of Ag as
AgNO3 exceeded the percent of the dose found in the duodenum
mucosa (P < 0.001) and muscularis (P = 0.007). This effect was not
observed in the Ag NP or Ag2S NP treatments.
3.3. Tissue fluid flux, moisture and electrolyte composition
There was no treatment-related effects in the fluid flux (Table 4) or
tissue moisture (data not shown). There were some significant changes
in the tissue electrolyte composition (Table 4). Throughout the gas-
trointestinal tract, the Na+ concentration ranged from 400 to
1000 μmol g−1 dw, depending on gut region, and did not significantly
alter between treatments. However, there were some significant
changes in the tissue K+ concentration. In general, the Ag NP treatment
had a more variable K+ concentration which resulted in some sig-
nificant differences compared to other treatments. For example, the K+
concentration in the duodenum of the Ag NP treatment was around
Table 2
The concentration of total Ag in the tissues and the serosal saline of gut sacs from rodents after 4 h of exposure.
Treatme-
nt
Sample type Oesophagus Stomach Duodenum Jejunum Ileum Hind intestine
Control Mucosa (ng g−1)
Muscularis (ng g−1)
% in mucosa

























AgNO3 Mucosa (ng g−1)
Muscularis (ng g−1)
% in mucosa

























Ag NPs Mucosa (ng g−1)
Muscularis (ng g−1)
% in mucosa

























Ag2S NPs Mucosa (ng g−1)
Muscularis (ng g−1)
% in mucosa

























Data are mean ± S.E.M. (n = 5/6). Total Ag concentrations are expressed as ng g−1 dry weight. Different upper case letters denote significant difference between
treatments for the same sample type (two-way ANOVA, columns). Lower case letters denote difference between gut regions within treatments (two-way ANOVA,
rows). The limit of detection of the instrument was 0.17 ng mL−1 which equates to 10.6 ng g−1 in tissue samples. The limit of detection for the serosal solution was
0.25 ng mL−1 which equates to 1.25 ng mL−1.
Table 3
Partitioning of Ag distribution throughout the gut sac. The luminal rinse, EDTA wash, the mucosa and muscularis expressed as the percentage of Ag dosed at the start
of the 4 h incubation.













































































































Data are mean ± S.E.M. (n = 5/6). Values are percentages (%). Different upper case letters denote statistical difference between gut regions of different treatments
(two-way ANOVA; columns). Different lower case letters denotes statistical difference between gut regions within the same treatment (two-way ANOVA; columns).
One-way ANOVA or Kruskal-Wallis was used for significant differences within each gut sac where (*) denotes significant difference from luminal rinse, (#) denotes
significant difference compared to EDTA wash and (^) denotes significant difference compared to the serosal saline. Note N/D equates to 0% as no total Ag was
detected – the statistical notation included is only for positive values for clarity.
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290 μmol g−1 dw, twice that of the AgNO3 treatment which had
130 μmol g−1 dw of K+ (P = 0.021). Despite some variability in the K+
concentrations, none of the Ag treatments were significantly elevated
compared to the controls.
4. Discussion
This study is the first to demonstrate the utility of the rodent gut sac
technique for the bioaccumulation potential of different forms of silver,
including ENMs. The highest accumulation of Ag from exposure to
AgNO3, Ag NPs or Ag2S NPs were in the duodenum, jejunum and ileum.
Specifically, the AgNO3 and Ag NP treatments showed evidence of
transepithelial accumulation of total Ag into the serosal compartment
for the duodenum. Regardless of the material added, the biologically
incorporated Ag (i.e., that in the mucosa, muscularis and serosal saline
together) was 22% or much less of the dose administered into the gut
lumen. Of this, only 14% or less was bioavailable to the serosal com-
partment, except in the Ag2S NP treatment where the serosal com-
partment did not show any detectable Ag, suggesting this treatment had
a lower bioavailability compared to the pristine Ag NPs or AgNO3.
4.1. Bioavailability of the metal salt and nanomaterials in the gut
The initial step in dissolved metal or ENM uptake is to make the test
substance in the gut lumen bioaccessible to the unstirred layer of mucus
on the surface of the gut. For dissolved metals, this depends heavily on
their chemical speciation (e.g., Pb, Oomen et al., 2003). The chemical
speciation of AgNO3 in the gut saline was calculated using Visual
MINTEQ and showed only a tiny fraction of Ag+; with most of the total
Ag present as less soluble chloride complexes, as expected for a saline
which contains some 120 mmol of chloride (Clark et al., 2019b). The
AgCl complex is sparingly soluble and will precipitate onto the surface
of the tissue (Clark et al., 2019b) and can therefore be washed off
(Table 1). Consequently, the bioavailable fraction to the mucosa was
6% or less of the dose (Table 3). There appears to be no gut sac studies
of AgNO3 in rodents, but these findings are similar to those for gut sacs
of rainbow trout where 9% or less of the dose was in the mucosa (Clark
et al., 2019b).
With regards to Ag NPs and Ag2S NPs, the same approach to saline
preparation was used here as in Clark et al. (2019b), which produced
reasonable dispersions despite the high ionic concentration of the gut
saline (Fig. 1). Dissolution of Ag from Ag NPs in the gut saline was tiny,
and absent for the Ag2S materials [see Clark et al. (2019b)]. It is
therefore likely that the gut mucosa was initially exposed to dispersions
of particles that settled onto the gut mucus and/or surface of the gut
epithelium. Any surface bound total Ag from these exposures was
readily washed off from the mucosa as evidenced from the higher
concentrations of Ag in the luminal and EDTA washes (Table 1). This
left only 5% or less of the dose bound on/in the mucosa. Thus, as ob-
served in trout (Clark et al., 2019b), the nanomaterials are labile and
most of the dose can be washed from the surface of the gut tissues.
Similarly for Ag NPs in Caco-2 cells, some 1–6% of the dose is asso-
ciated with the cells, depending on the size of the nanomaterial (van der
Zande et al., 2016).
4.2. Total silver accumulation in the gut tissue
While gut sacs have some limitations for quantifying the uptake of
chemicals (Foulkes, 1996), they retain most of the intrinsic physiolo-
gical properties of the gut barrier, such as the transepithelial potential
and solute permeability (Foulkes and Bergman, 1993; Handy et al.,
2000). The gut sacs here were viable as shown by normal electrolyte
concentrations and water fluxes (Table 4); with the latter comparable to
previous water flux movements of typically around 10–30 μL g−1 h−1
in gut sacs from the small intestine of rodents (Birge et al., 1972). The
water flux in gut sacs from the rat are also an order of magnitude lower
than freshwater trout (Clark et al., 2019b); and in keeping with the
requirement of terrestrial species to conserve water.
The intestinal ion transporters involved in the uptake of Ag+ and
any soluble anionic complexes of silver are uncertain, but Ag+ shares
some similarities with the Cu+ ion that is transported across the in-
testine (Puchkova, 2019). The accumulation of the Ag from the AgNO3
treatment into the epithelial cells of the gut mucosa would involve fa-
cilitated diffusion through the apical membrane and down the elec-
trochemical gradient, perhaps via the apical copper transporter one
(Ctr1), or divalent metal transporter 1 (DMT1) that will carry a variety
of metals (Gunshin et al., 1997). Tentatively, any intracellular Ag+
might be moved through the cell by Cu+ chaperones, and then be ex-
ported by vesicular trafficking through the Golgi apparatus involving
the Cu-ATPases (Puchkova, 2019). The copper transport system in the
gut is also hijacked by other non-essential toxic metals such as Hg
(Hoyle and Handy, 2005). Regardless of the mechanisms, the export of
any dissolved Ag from inside the gut epithelial cells to the serosal
compartment will be active and against the electrochemical gradient.
Table 4
Fluid flux, accumulation rate of total Ag into the mucosa and tissue electrolyte concentration in the rodent gut sac.
Measurement Treatment Oesophagus Stomach Duodenum Jejunum Ileum Hind intestine
































































































155 ± 21 AB
129 ± 18A
292 ± 54B
180 ± 34 AB
181 ± 23 AB
88 ± 15A
258 ± 48B
188 ± 21 AB
161 ± 29 AB







Data are mean ± S.E.M. (n = 5/6). Different upper case letters denote significant difference between treatments (columns). Different lower case letters denote
significant difference between gut regions (rows). There was no significant difference in the fluid flux between treatments (one-way ANOVA or Kruskal-Wallis). A
two-way ANOVA was used to analyse the accumulation rate into mucosa only (treatment and gut region). A one-way ANOVA or Kruskal-Wallis was used to analyse
the fluid flux, Na+ and K+ concentrations (treatment). Note, a negative fluid flux value indicates a net loss of water from the animal to the gut lumen, when the flux is
zero the water is in net balance.
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Crucially, the Ag accumulation in the mucosa is not explained by sol-
vent drag, as the metal flux is arguably smaller (i.e., different) and
sometime in the opposite direction to that of the water (Table 4). This is
consistent with previous measurements of the intrinsic permeability of
the rat intestine (e.g., to ethanol) that only partly explain metal uptake
(Foulkes and Bergman, 1993). The tissue accumulation rates into the
mucosa of the gut for Ag from AgNO3 were 10–17 nmol g−1 h−1
(Table 4), with the highest rate in the jejunum and ileum. These are
slightly higher compared to that in the mid intestine of trout
[~9 nmol g−1 h−1, Clark et al. (2019b)], as might be expected at the
higher body temperature of mammals. However, the uptake rates for
the metal salt (Table 4) are consistent with other reports in rodents for
metals. For example, Cu in the in situ perfused rat intestine, about
22 nmol g−1 h−1 (Wapnir, 1991). They are also broadly in the same
magnitude as the uptake rates for Ca and Mg into the duodenal mucosa
of ~5 and 2 nmol cm2 g−1 (O'Donnell and Smith, 1973).
Nanomaterials are far too large to be taken up on solute transports
(Handy et al., 2008) including the ion transporters involved in dis-
solved Ag uptake (ionic radius of Ag+, ~115 pm). Nonetheless, for the
nanomaterials, the pattern of accumulation of total Ag (form unknown
in the tissue) from the Ag NP exposure was broadly the same as AgNO3,
except that the muscularis accumulated less Ag, and the serosal con-
centration was mostly at or below the detection limit (Table 2). This
implies some Ag was taken up into the gut epithelium, but not much
was exported to the serosal side during the 4 h incubation. This is in
keeping with oral gavage studies in vivo that show Ag NP exposures
result in less Ag accumulation in the gut wall compared to the metal salt
controls (van der Zande et al., 2012). Notably for the Ag NP exposures
here, only the duodenum showed some net transepithelial uptake of
total Ag to the serosal compartment (Table 2). Some total Ag uptake
into the blood, and subsequently to the internal organs, from Ag NP
exposures has also been demonstrated in oral gavage studies with ro-
dents (Loeschner et al., 2011; van der Zande et al., 2012). Furthermore,
Loeschner et al. (2011), reported silver containing particles below the
epithelial cells in the lamina propria of the lacteal region of the in-
testinal villus of the ileum, as well as some silver staining in the sub-
mucosa. This implies uptake of intact Ag NPs in the rat gut (e.g., by
endocytosis), but once translocated through the epithelial cells, the Ag-
containing material was captured by macrophages in the lacteal
(Loeschner et al., 2011). This is consistent with the notion of ENMs
being incorporated into the lymphatics of the villus, not the underlying
musculature itself. Clark et al. (2019c) also confirmed, using single
particle inductively coupled plasma mass spectrometry (spICP-MS), the
likely internalisation of intact Ag NPs into the livers of trout fed diets
containing the same Ag NPs used here.
In contrast to the Ag NP treatment, Ag from the Ag2S NP treatment
was less bioavailable in the duodenum, with no detectable Ag in the
serosal solution from any region of the gut (Table 2). The Ag2S NPs are
persistent, insoluble and show no silver dissolution (Clark et al.,
2019b), and so must be presented to the gut in the particulate form. The
anatomy of the gut barrier to ENMs is fundamentally similar in the
ileum and duodenum [see our recent review of comparative gut
anatomy with ENMs (van der Zande, 2020)] and the absorptive prop-
erties for substances are partly governed by the molecular character-
istics and locations of the transport mechanisms in these regions of the
gut. A role for the duodenum in the endocytosis of nanoparticles is
likely, since it expresses the genes such as those for caveolin-1 known to
be involved in endocytosis (Valasek et al., 2005), and also the genes
involved in vesicular metal trafficking (Ravia et al., 2005). The duo-
denum has also shown greater uptake of simvastatin-loaded lipid NPs
compared to the jejunum (Zhang et al., 2010). Additionally, gut sacs of
the duodenum preferentially accumulate chitosan microparticles
(11.5 μm) compared to the jejunum and ileum (da Silva et al., 2009).
The total Ag from Ag2S does appear in the muscularis (Table 2), ten-
tatively suggesting that some translocation of Ag2S NPs through epi-
thelial cells, but it does not appear in the serosal fluid. Clearly, Ag from
Ag2S NPs is less bioavailable and processed in a different way to Ag
from Ag NP exposures in the duodenum. Lower dietary bioavailability
of the same Ag2S NPs compared to Ag NPs used here has also been
confirmed in vivo in trout (Clark et al., 2019a). The Ag2S NPs had a
slightly smaller primary diameter than the Ag NPs, so endocytosis of the
former might result in slightly less total Ag in the tissue on a mass basis,
or alternatively, smaller particles might be taken up at different rates to
larger particles, both via distinct pathways. The mechanistic role of the
intestine in differentiating forms of Ag-containing materials requires
further investigation.
4.3. Conclusions and regulatory perspectives
In conclusion, the gut sac technique using rats can be employed to
demonstrate the bioaccumulation potential of different Ag materials.
The Ag bioavailability is only a modest fraction of the total dose, and
based on the total Ag accumulation in the serosal saline of the duo-
denum, the gut sac method ranks the silver materials in the order:
AgNO3 > Ag NPs > Ag2S NPs. This ranking suggesting that any ex-
isting oral bioaccumulation assessment for the dissolved metal would
also be protective over the nano forms of silver. This is a similar ranking
to previous gut sac studies in trout, where the materials were ranked in
the order: AgNO3 > Ag NPs = Ag2S NPs. In the European Union, the
28-day oral toxicity tests [e.g., TG 407, OECD (2008)], or a similar
protocol using rodents is a mandatory requirement for the registration
of new substances and oral medicines where ingestion may be a con-
cern. The EU directive 2010/63/EU on animal welfare also requires the
minimal use of vertebrate animal testing. The TG 407 requires ten an-
imals at each dose, at least three doses and a control; so not less than
forty animals per test with potential for harm and distress over the
twenty-eight days of the protocol. This compares to only five or six
animals for the ex vivo gut sac method (i.e., reduction in animal use),
and since the latter is on the gut removed after humane euthanasia, the
distress to animals is also minimal. The gut sac method may enable a
decision to waive TG 407 and similar in vivo tests entirely (i.e., re-
placement of animal use). We recommend that the rat gut sac method
could be used to screen out ENMs that are not taken up by the gut, so
that only materials ‘of concern’ go forward to in vivo animal testing in
rodents. However, in the oral toxicity testing strategy for mammals, the
replacement of the in vivo tests with in vitro alternative has not yet been
realised. For ENMs, where materials might be made in a plethora of
shapes and sizes of the same chemical substance, a tiered approach to
oral toxicity testing is especially desirable; as we have suggested for
environmental effects testing for the bioaccumulation potential of
ENMs in fish (Handy et al., 2018). The gut sac method is also much
closer to the in vivo condition than, for example, a gut cell line. How-
ever, both cell lines and gut sacs are closed systems and have some
limitations for flux measurements. The metal accumulation in the gut
sac is therefore intended as a predictive tool for the in vivo bioaccu-
mulation hazard. It is also important to understand the mechanism of
uptake across the gut epithelium, so that preventative measures can be
put in place, such as safe-by-design manufacturing of ENMs, or re-
medies for acute oral poisoning. Here, the gut sac method may also find
utility, such as using ion transport and/or endocytosis inhibitors to
investigate the pathways involved.
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